|
1
|
Bottacini F, van Sinderen D and Ventura M:
Omics of bifidobacteria: Research and insights into their
health-promoting activities. Biochem J. 474:4137–4152. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Biarc J, Nguyen IS, Pini A, Gossé F,
Richert S, Thiersé D, Van Dorsselaer A, Leize-Wagner E, Raul F,
Klein JP and Schöller-Guinard M: Carcinogenic properties of
proteins with pro-inflammatory activity from Streptococcus
infantarius (formerly S. bovis). Carcinogenesis. 25:1477–1484.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wei C, Xun AY, Wei XX, Yao J, Wang JY, Shi
RY, Yang GH, Li YX, Xu ZL, Lai MG, et al: Bifidobacteria expressing
tumstatin protein for antitumor therapy in tumor-bearing mice.
Technol Cancer Res Treat. 15:498–508. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liboredo JC, Anastácio LR, Pelúzio Mdo C,
Valente FX, Penido LC, Nicoli JR and Correia MI: Effect of
probiotics on the development of dimethylhydrazine-induced
preneoplastic lesions in the mice colon. Acta Cir Bras. 28:367–372.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lai LR, Hsieh SC, Huang HY and Chou CC:
Effect of lactic fermentation on the total phenolic, saponin and
phytic acid contents as well as anti-colon cancer cell
proliferation activity of soymilk. J Biosci Bioeng. 115:552–556.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim KA, Jung IH, Park SH, Ahn YT, Huh CS
and Kim DH: Comparative analysis of the gut microbiota in people
with different levels of ginsenoside Rb1 degradation to compound K.
PloS One. 8:e624092013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schroeder BO, Birchenough GMH, Stahlman M,
Arike L, Johansson MEV, Hansson GC and Bäckhed F: Bifidobacteria or
fiber protects against diet-induced microbiota-mediated colonic
mucus deterioration. Cell Host Microbe. 23:27–40.e7. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thum C, Roy NC, McNabb WC, Otter DE and
Cookson AL: In vitro fermentation of caprine milk oligosaccharides
by bifidobacteria isolated from breast-fed infants. Gut Microbes.
6:352–363. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Asakuma S, Hatakeyama E, Urashima T,
Yoshida E, Katayama T, Yamamoto K, Kumagai H, Ashida H, Hirose J
and Kitaoka M: Physiology of consumption of human milk
oligosaccharides by infant gut-associated bifidobacteria. J Biol
Chem. 286:34583–34592. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ku S, You HJ, Park MS and Ji GE: Effects
of ascorbic acid on α-l-arabinofuranosidase and
α-l-arabinopyranosidase activities from RD47 and its application to
whole cell bioconversion of ginsenoside. J Korean Soc Appl Biol
Chem. 58:857–865. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Egan M, Motherway MO, Kilcoyne M, Kane M,
Joshi L, Ventura M and van Sinderen D: Cross-feeding by
Bifidobacterium breve UCC2003 during co-cultivation with
Bifidobacterium bifidum PRL2010 in a mucin-based medium. BMC
Microbiol. 14:2822014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bayoumi MA and Griffiths MW: In vitro
inhibition of expression of virulence genes responsible for
colonization and systemic spread of enteric pathogens using
Bifidobacterium bifidum secreted molecules. Int J Food Microbiol.
156:255–263. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim JE, Kim JY, Lee KW and Lee HJ: Cancer
chemopreventive effects of lactic acid bacteria. J Microbiol
Biotechnol. 17:1227–1235. 2007.PubMed/NCBI
|
|
14
|
Oikarinen S, Heinonen S, Karppinen S,
Mättö J, Adlercreutz H, Poutanen K and Mutanen M: Plasma
enterolactone or intestinal Bifidobacterium levels do not explain
adenoma formation in multiple intestinal neoplasia (Min) mice fed
with two different types of rye-bran fractions. Br J Nutr.
90:119–125. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bindels LB, Neyrinck AM, Salazar N,
Taminiau B, Druart C, Muccioli GG, Francois E, Blecker C, Richel A,
Daube G, et al: Non digestible oligosaccharides modulate the gut
microbiota to control the development of leukemia and associated
cachexia in mice. PloS One. 10:e01310092015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Silva Oliveira E, de Carvalho Cruz T,
Parshikov IA, dos Santos Alves R, Emery Silva F and Furtado
Jacometti Cardoso NA: Cytotoxicity of lapachol metabolites produced
by probiotics. Lett Appl Microbiol. 59:108–114. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hidaka A, Hamaji Y, Sasaki T, Taniguchi S
and Fujimori M: Exogenous cytosine deaminase gene expression in
Bifidobacterium breve I-53-8w for tumor-targeting enzyme/ prodrug
therapy. Biosci Biotechnol Biochem. 71:2921–2926. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nakamura T, Sasaki T, Fujimori M, Yazawa
K, Kano Y, Amano J and Taniguchi S: Cloned cytosine deaminase gene
expression of Bifidobacterium longum and application to
enzyme/pro-drug therapy of hypoxic solid tumors. Biosci Biotechnol
Biochem. 66:2362–2366. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bae EA, Park SY and Kim DH: Constitutive
beta-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human
intestinal bacteria. Biol Pharm Bull. 23:1481–1485. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Apás AL, Dupraz J, Ross R, González SN and
Arena ME: Probiotic administration effect on fecal mutagenicity and
microflora in the goat's gut. J Biosci Bioeng. 110:537–540. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lo PR, Yu RC, Chou CC and Huang EC:
Determinations of the antimutagenic activities of several probiotic
bifidobacteria under acidic and bile conditions against
benzo[a]pyrene by a modified Ames test. Int J Food Microbiol.
93:249–257. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Osswald A, Westermann C, Sun Z and Riedel
CU: A phytase-based reporter system for identification of
functional secretion signals in bifidobacteria. PloS One.
10:e01288022015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiang L, Xiao X, Ren J, Tang Y, Weng H,
Yang Q, Wu M and Tang W: Proteomic analysis of bladder cancer
indicates Prx-I as a key molecule in BI-TK/GCV treatment system.
PloS One. 9:e987642014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xiao X, Jin R, Li J, Bei Y and Wei T: The
antitumor effect of suicide gene therapy using Bifidobacterium
infantis-mediated herpes simplex virus thymidine kinase/ganciclovir
in a nude mice model of renal cell carcinoma. Urology. 84(982):
e15–e20. 2014.PubMed/NCBI
|
|
25
|
Reddy BS: Possible mechanisms by which
pro- and prebiotics influence colon carcinogenesis and tumor
growth. J Nutr. 129 7 Suppl:S1478–S1482. 1999. View Article : Google Scholar
|
|
26
|
Rodrigues MA, Silva LA, Salvadori DM, De
Camargo JL and Montenegro MR: Aberrant crypt foci and colon cancer:
Comparison between a short- and medium-term bioassay for colon
carcinogenesis using dimethylhydrazine in Wistar rats. Braz J Med
Biol Res. 35:351–355. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kulkarni N and Reddy BS: Inhibitory effect
of Bifidobacterium longum cultures on the azoxymethane-induced
aberrant crypt foci formation and fecal bacterial
beta-glucuronidase. Proc Soc Exp Biol Med. 207:278–283. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Femia AP, Luceri C, Dolara P, Giannini A,
Biggeri A, Salvadori M, Clune Y, Collins KJ, Paglierani M and
Caderni G: Antitumorigenic activity of the prebiotic inulin
enriched with oligofructose in combination with the probiotics
Lactobacillus rhamnosus and Bifidobacterium lactis on
azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis.
23:1953–1960. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yin Y, Wang RR, Wang Y, Wang JJ and Xu GX:
Preparation of selenium-enriched Bifidobacterium longum and its
effect on tumor growth and immune function of tumor-bearing mice.
Asian Pac J Cancer Prev. 15:3681–3686. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sekine K, Toida T, Saito M, Kuboyama M,
Kawashima T and Hashimoto Y: A new morphologically characterized
cell wall preparation (whole peptidoglycan) from Bifidobacterium
infantis with a higher efficacy on the regression of an established
tumor in mice. Cancer Res. 45:1300–1307. 1985.PubMed/NCBI
|
|
31
|
Rowland IR, Rumney CJ, Coutts JT and
Lievense LC: Effect of Bifidobacterium longum and inulin on gut
bacterial metabolism and carcinogen-induced aberrant crypt foci in
rats. Carcinogenesis. 19:281–285. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Simone M, Gozzoli C, Quartieri A, Mazzola
G, Di Gioia D, Amaretti A, Raimondi S and Rossi M: The probiotic
Bifidobacterium breve B632 inhibited the growth of
Enterobacteriaceae within colicky infant microbiota cultures.
Biomed Res Int. 2014:3010532014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mogna L, Del Piano M and Mogna G:
Capability of the two microorganisms Bifidobacterium breve B632 and
Bifidobacterium breve BR03 to colonize the intestinal microbiota of
children. J Clin Gastroenterol. 48 Suppl 1:S37–S39. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fooks LJ and Gibson GR: Probiotics as
modulators of the gut flora. Br J Nutr. 88 Suppl 1:S39–S49. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dhanani AS and Bagchi T: Lactobacillus
plantarum CS24.2 prevents E. coli adhesion to HT-29 cells and also
down-regulates enteropathogen induced TNF-α and IL-8 expression.
Microbiol Immunol. 57:309–315. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tareb R, Bernardeau M, Gueguen M and
Vernoux JP: In vitro characterization of aggregation and adhesion
properties of viable and heat-killed forms of two probiotic
Lactobacillus strains and interaction with foodborne zoonotic
bacteria, especially Campylobacter jejuni. J Med Microbiol.
62:637–649. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kolenbrander PE, Palmer RJ Jr, Periasamy S
and Jakubovics NS: Oral multispecies biofilm development and the
key role of cell-cell distance. Nat Rev Microbiol. 8:471–480. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cadieux PA, Burton J, Devillard E and Reid
G: Lactobacillus by-products inhibit the growth and virulence of
uropathogenic Escherichia coli. J Physiol Pharmacol. 60 Suppl
6:S13–S18. 2009.
|
|
39
|
McMillan A, Dell M, Zellar MP, Cribby S,
Martz S, Hong E, Fu J, Abbas A, Dang T, Miller W and Reid G:
Disruption of urogenital biofilms by lactobacilli. Colloids Surf B
Biointerfaces. 86:58–64. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Velraeds MM, van de Belt-Gritter B, van
der Mei HC, Reid G and Busscher HJ: Interference in initial
adhesion of uropathogenic bacteria and yeasts to silicone rubber by
a Lactobacillus acidophilus biosurfactant. J Med Microbiol.
47:1081–1085. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Apás AL, González SN and Arena ME:
Potential of goat probiotic to bind mutagens. Anaerobe. 28:8–12.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Asaduzzaman SM and Sonomoto K:
Lantibiotics: Diverse activities and unique modes of action. J
Biosci Bioeng. 107:475–487. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xu HY, Tian WH, Wan CX, Jia LJ, Wang LY,
Yuan J, Liu CM, Zeng M and Wei H: Antagonistic potential against
pathogenic microorganisms and hydrogen peroxide production of
indigenous lactobacilli isolated from vagina of Chinese pregnant
women. Biomed Environ Sci. 21:365–371. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Martín R and Suárez JE: Biosynthesis and
degradation of H2O2 by vaginal lactobacilli. Appl Environ
Microbiol. 76:400–405. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lankaputhra WE and Shah NP: Antimutagenic
properties of probiotic bacteria and of organic acids. Mutat Res.
397:169–182. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sreekumar O and Hosono A: The
antimutagenic properties of a polysaccharide produced by
Bifidobacterium longum and its cultured milk against some
heterocyclic amines. Can J Microbiol. 44:1029–1036. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Reddy BS: Prevention of colon cancer by
pre- and probiotics: Evidence from laboratory studies. Br J Nutr.
80:S219–S223. 1998.PubMed/NCBI
|
|
48
|
Singh J, Rivenson A, Tomita M, Shimamura
S, Ishibashi N and Reddy BS: Bifidobacterium longum, a lactic
acid-producing intestinal bacterium inhibits colon cancer and
modulates the intermediate biomarkers of colon carcinogenesis.
Carcinogenesis. 18:833–841. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Verma A and Shukla G: Probiotics
Lactobacillus rhamnosus GG, Lactobacillus acidophilus suppresses
DMH-induced procarcinogenic fecal enzymes and preneoplastic
aberrant crypt foci in early colon carcinogenesis in Sprague Dawley
rats. Nutr Cancer. 65:84–91. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Lee do K, Jang S, Baek EH, Kim MJ, Lee KS,
Shin HS, Chung MJ, Kim JE, Lee KO and Ha NJ: Lactic acid bacteria
affect serum cholesterol levels, harmful fecal enzyme activity, and
fecal water content. Lipids Health Dis. 8:212009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Suerbaum S and Michetti P: Helicobacter
pylori infection. N Engl J Med. 347:1175–1186. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Swidsinski A, Khilkin M, Kerjaschki D,
Schreiber S, Ortner M, Weber J and Lochs H: Association between
intraepithelial Escherichia coli and colorectal cancer.
Gastroenterology. 115:281–286. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Abdulamir AS, Hafidh RR, Mahdi LK,
Al-jeboori T and Abubaker F: Investigation into the controversial
association of Streptococcus gallolyticus with colorectal cancer
and adenoma. BMC Cancer. 9:4032009. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Gupta A, Madani R and Mukhtar H:
Streptococcus bovis endocarditis, a silent sign for colonic tumour.
Colorectal Dis. 12:164–171. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Bernet MF, Brassart D, Neeser JR and
Servin AL: Adhesion of human bifidobacterial strains to cultured
human intestinal epithelial cells and inhibition of
enteropathogen-cell interactions. Appl Environ Microbiol.
59:4121–4128. 1993.PubMed/NCBI
|
|
57
|
Kavanaugh DW, O'Callaghan J, Buttó LF,
Slattery H, Lane J, Clyne M, Kane M, Joshi L and Hickey RM:
Exposure of Bifidobacterium longum subsp. infantis to milk
oligosaccharides increases adhesion to epithelial cells and induces
a substantial transcriptional response. PloS One. 8:e672242013.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Wickramasinghe S, Pacheco AR, Lemay DG and
Mills DA: Bifidobacteria grown on human milk oligosaccharides
downregulate the expression of inflammation-related genes in Caco-2
cells. BMC Microbiol. 15:1722015. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Chichlowski M, De Lartigue G, German JB,
Raybould HE and Mills DA: Bifidobacteria isolated from infants and
cultured on human milk oligosaccharides affect intestinal
epithelial function. J Pediatr Gastroenterol Nutr. 55:321–327.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Gu QY, Zhang J and Feng YC: Role of NLRP3
inflammasome in Bifidobacterium longum-regulated visceral
hypersensitivity of postinfectious irritable bowel syndrome. Artif
Cells Nanomed Biotechnol. 44:1933–1937. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Wu BB, Yang Y, Xu X and Wang WP: Effects
of Bifidobacterium supplementation on intestinal microbiota
composition and the immune response in healthy infants. World J
Pediatr. 12:177–182. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Wu S, Rhee KJ, Albesiano E, Rabizadeh S,
Wu X, Yen HR, Huso DL, Brancati FL, Wick E, McAllister F, et al: A
human colonic commensal promotes colon tumorigenesis via activation
of T helper type 17 T cell responses. Nat Med. 15:1016–1022. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Mortaz E, Adcock IM, Folkerts G, Barnes
PJ, Vos Paul A and Garssen J: Probiotics in the management of lung
diseases. Mediators Inflamm. 2013:7510682013. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Helwig U, Lammers KM, Rizzello F, Brigidi
P, Rohleder V, Caramelli E, Gionchetti P, Schrezenmeir J, Foelsch
UR, Schreiber S and Campieri M: Lactobacilli, bifidobacteria and E.
coli nissle induce pro- and anti-inflammatory cytokines in
peripheral blood mononuclear cells. World J Gastroenterol.
12:5978–5986. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Korn T, Bettelli E, Oukka M and Kuchroo
VK: IL-17 and Th17 cells. Ann Rev Immunol. 27:485–517. 2009.
View Article : Google Scholar
|
|
66
|
Lin W, Truong N, Grossman WJ, Haribhai D,
Williams CB, Wang J, Martin MG and Chatila TA: Allergic
dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice. J
Allergy Clin Immunol. 116:1106–1115. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Feleszko W, Jaworska J, Rha RD,
Steinhausen S, Avagyan A, Jaudszus A, Ahrens B, Groneberg DA, Wahn
U and Hamelmann E: Probiotic-induced suppression of allergic
sensitization and airway inflammation is associated with an
increase of T regulatory-dependent mechanisms in a murine model of
asthma. Clin Exp Allergy. 37:498–505. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Sivan A, Corrales L, Hubert N, Williams
JB, Aquino-Michaels K, Earley ZM, Benyamin FW, Lei YM, Jabri B,
Alegre ML, et al: Commensal Bifidobacterium promotes antitumor
immunity and facilitates anti-PD-L1 efficacy. Science.
350:1084–1089. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Yin Y, Kou L, Wang JJ and Xu GX:
Therapeutic efficacy of Bifidobacterium longum-mediated human
interleukin-2 with endostatin or TRAIL in transplanted tumors in
mice. Exp Ther Med. 3:481–486. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Bordonaro M, Lazarova DL and Sartorelli
AC: Butyrate and Wnt signaling: A possible solution to the puzzle
of dietary fiber and colon cancer risk? Cell Cycle. 7:1178–1183.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Mäkivuokko H, Tiihonen K, Tynkkynen S,
Paulin L and Rautonen N: The effect of age and non-steroidal
anti-inflammatory drugs on human intestinal microbiota composition.
Br J Nutr. 103:227–234. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Bergmann KR, Liu SX, Tian R, Kushnir A,
Turner JR, Li HL, Chou PM, Weber CR and De Plaen IG: Bifidobacteria
stabilize claudins at tight junctions and prevent intestinal
barrier dysfunction in mouse necrotizing enterocolitis. Am J
Pathol. 182:1595–1606. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Ewaschuk JB, Diaz H, Meddings L,
Diederichs B, Dmytrash A, Backer J, Looijer-van Langen M and Madsen
KL: Secreted bioactive factors from Bifidobacterium infantis
enhance epithelial cell barrier function. Am J Physiol Gastrointest
Liver Physiol. 295:G1025–G1034. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Becker S, Oelschlaeger TA, Wullaert A,
Vlantis K, Pasparakis M, Wehkamp J, Stange EF and Gersemann M:
Bacteria regulate intestinal epithelial cell differentiation
factors both in vitro and in vivo. PloS One. 8:e556202013.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
de Vrese M and Schrezenmeir J: Probiotics,
prebiotics, and synbiotics. Adv Biochem Eng Biotechnol. 111:1–66.
2008.PubMed/NCBI
|
|
76
|
Ricciuti B, Foglietta J, Bianconi V,
Sahebkar A and Pirro M: Enzymes involved in tumor-driven
angiogenesis: A valuable target for anticancer therapy. Semin
Cancer Biol: S1044-579X(17)30043-3. 2017. View Article : Google Scholar
|
|
77
|
Zhu H, Li Z, Mao S, Ma B, Zhou S, Deng L,
Liu T, Cui D, Zhao Y, He J, et al: Antitumor effect of sFlt-1 gene
therapy system mediated by Bifidobacterium infantis on Lewis lung
cancer in mice. Cancer Gene Ther. 18:884–896. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Sudhakar A and Boosani CS: Inhibition of
tumor angiogenesis by tumstatin: Insights into signaling mechanisms
and implications in cancer regression. Pharm Res. 25:2731–2739.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Wei C, Xun AY, Wei XX, Yao J, Wang JY, Shi
RY, Yang GH, Li YX, Xu ZL, Lai MG, et al: Bifidobacteria expressing
tumstatin protein for antitumor therapy in tumor-bearing mice.
Technol Cancer Res Treat. 15:498–508. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Yi C, Huang Y, Guo ZY and Wang SR:
Antitumor effect of cytosine deaminase/5-fluorocytosine suicide
gene therapy system mediated by Bifidobacterium infantis on
melanoma. Acta Pharmacol Sin. 26:629–634. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Sasaki T, Fujimori M, Hamaji Y, Hama Y,
Ito K, Amano J and Taniguchi S: Genetically engineered
Bifidobacterium longum for tumor-targeting enzyme-prodrug therapy
of autochthonous mammary tumors in rats. Cancer Sci. 97:649–657.
2006. View Article : Google Scholar : PubMed/NCBI
|
